May 17, 2020

NHS heroes recognized by ID Medical

Admin
2 min
ID Medical joins BBC Look North’s Clare Frisby to recognise NHS heroes.jpg
Written by Caryn Cooper ID Medical, the main sponsor of theDoncaster and Bassetlaw Hospitals NHS Foundation Trusts annual STARS Awards 2013, joinedBBC...

Written by Caryn Cooper

ID Medical, the main sponsor of the Doncaster and Bassetlaw Hospitals NHS Foundation Trust’s annual STARS Awards 2013, joined BBC Look North’s Clare Frisby at the Premier Suite, Doncaster Racecourse on Thursday 19th September 2013 to present NHS staff and volunteers with their merited awards.

Organisers of the DBH STARS Awards 2013, part of Doncaster and Bassetlaw Hospitals NHS Foundation Trust’s STaff Awards & Recognition Scheme, welcomed over 300 Trust staff, guests and partners this year.

Nick Napier-Andrews (pictured), head of strategic accounts at ID Medical presented Christine Malloch, paediatric dietitian (pictured) and Stephen Fill, service assistant, with the unsung hero/heroine award, and later stepped on stage to announce the winner of the esteemed Star of the Month Award, Sister Nikki Walker from Theatres for her excellent leadership and management skills.

On reflection, Nick Napier-Andrews commented, “To present such admirable NHS staff with an award is a truly humbling experience and as an organisation, ID Medical is privileged to be invited to partner with Trusts such as DBH that are organising celebratory events to recognise staff in times of trepidation within the NHS. 

“To continue on a path towards excellence, NHS Trusts, including DBH, are working to instil a positive notion into the workforce to ensure a high level of patient care, and this can be directly correlated with the efficient and innovative recruitment solutions that ID Medical provides to both candidates and clients.”

About ID Medical

ID Medical (HQ in Milton Keynes with office in central London) was established in 2002 and has since maintained its enviable position as market leader in the provision of high calibre medical staffing to both the public and private sectors. As the UK’s leading provider of locum doctors, nurses, AHP/HSS and clerical staff, ID Medical holds preferred supplier contracts with over 80% of hospitals nationwide and supplies over 2 million hours to the NHS per annum.

Founded on its core principles of quality of service, dedication, innovation and commitment, the ID Medical Group Limited provides a complete medical staffing solution to its valued partners, forming part of the NHS procurement.

2013 has been a year filled with recognition of ID Medical’s first-rate capacity to provide a premier level service to its valued candidates and clients, with the company firmly positioned within the annual Recruiter FAST 50 league, Sunday Times 100 Best Companies to Work for 2013, Investec Hot 100, Recruitment International Top 250 and the REC IRP Awards 2013. This demonstrates ID Medical’s commitment to the industry whilst validating its credibility as market leader.

 

 

Share article

Jun 23, 2021

Introducing Dosis - the AI powered dosing platform

AI
medication
personalisedmedicine
chronicdisease
3 min
Dosis is an AI-powered personalised medication dosing platform that's on a mission to transform chronic disease management

Cloud-based platform Dosis uses AI to help patients and clinicians tailor their medication plans. Shivrat Chhabra, CEO and co-founder, tells us how it works. 

When and why was Dosis founded?
Divya, my co-founder and I founded Dosis in 2017 with the purpose of creating a personalised dosing platform. We see personalisation in so many aspects of our lives, but not in the amount of medication we receive. We came across some research at the University of Louisville that personalised the dosing of a class of drugs called ESAs that are used to treat chronic anaemia. We thought, if commercialised, this could greatly benefit the healthcare industry by introducing precision medicine to drug dosing. 

The research also showed that by taking this personalised approach, less drugs were needed to achieve the same or better outcomes. That meant that patients were exposed to less medication, so there was a lower likelihood of side effects. It also meant that the cost of care was reduced. 

What is the Strategic Anemia Advisor? 
Dosis’s flagship product, Strategic Anemia Advisor (SAA), personalises the dosing of Erythropoiesis Stimulating Agents (ESAs). ESAs are a class of drugs used to treat chronic anaemia, a common complication of chronic kidney disease. 

SAA takes into account a patient’s previous ESA doses and lab levels, determines the patient’s unique response to the drug and outputs an ESA dose recommendation to keep the patient within a specified therapeutic target range. Healthcare providers use SAA as a clinical decision support tool. 

What else is Dosis working on? 
In the near term, we are working on releasing a personalised dosing module for IV iron, another drug that’s used in tandem with ESAs to treat chronic anaemia. We’re also working on personalising the dosing for the three drugs used to treat Mineral Bone Disorder. We’re very excited to expand our platform to these new drugs. 

What are Dosis' strategic goals for the next 2-3 years? 
We strongly believe that personalised dosing will be the standard of care within the next decade, and we’re honored to be a part of making that future a reality. In the next few years, we see Dosis entering partnerships with other companies that operate within value-based care environments, where tools like ours that help reduce cost while maintaining or improving outcomes are extremely useful.

What do you think AI's greatest benefits to healthcare are?
If designed well, AI in healthcare allows for a practical and usable way to deploy solutions that would not be feasible otherwise. For example, it’s possible for someone to manually solve the mathematical equations necessary to personalise drug dosing, but it is just not practical. AI in healthcare offers an exciting path forward for implementing solutions that for so long have appeared impractical or impossible.

Share article